DVAX Dynavax Technologies PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: DVAX
- PE Ratio
The current PE ratio of DVAX cannot be calculated, as the latest EPS of -$0.49 is negative. The last PE ratio of Dynavax Technologies, recorded in December 2024, was 60.81.
DVAX PE ratio history
The PE ratio of Dynavax Technologies has averaged 41.67 over the last four years. Looking back at the last four years, DVAX's PE ratio peaked in the Mar 2024 quarter at 177.29, when the price was $12.41 and the EPS was $0.07. The lowest point was in the Sep 2022 quarter, when it reached 4.02 with a price of $10.44 and an EPS of $2.6.
Dynavax Technologies PE ratio by year
Maximum annual decrease: -79.77% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 60.81 | N/A | $12.77 | $0.21 |
| 2023 | N/A | N/A | $13.98 | -$0.05 |
| 2022 | 4.59 | -79.77% | $10.64 | $2.32 |
| 2021 | 22.69 | N/A | $14.07 | $0.62 |
| 2020 | N/A | N/A | $4.45 | -$0.75 |
| 2019 | N/A | N/A | $5.72 | -$2.16 |
| 2018 | N/A | N/A | $9.15 | -$2.55 |
| 2017 | N/A | N/A | $18.7 | -$1.81 |
| 2016 | N/A | N/A | $3.95 | -$2.92 |
| 2015 | N/A | N/A | $24.16 | -$3.25 |
| 2014 | N/A | N/A | $16.86 | -$3.45 |
| 2013 | N/A | N/A | $19.6 | -$3.83 |
| 2012 | N/A | N/A | $28.5 | -$4.1 |
| 2011 | N/A | N/A | $33.2 | -$3.9 |
| 2010 | N/A | N/A | $32 | -$6.9 |
Dynavax Technologies PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | N/A | N/A | $12.97 | -$0.49 |
| Dec 2024 | 60.81 | -18.12% | $12.77 | $0.21 |
| Sep 2024 | 74.27 | -14.02% | $11.14 | $0.15 |
| Jun 2024 | 86.38 | -51.28% | $11.23 | $0.13 |
| Mar 2024 | 177.29 | N/A | $12.41 | $0.07 |
| Dec 2023 | N/A | N/A | $13.98 | -$0.05 |
| Sep 2023 | 30.77 | 107.21% | $14.77 | $0.48 |
| Jun 2023 | 14.85 | 181.78% | $12.92 | $0.87 |
| Mar 2023 | 5.27 | 14.81% | $9.81 | $1.86 |
| Dec 2022 | 4.59 | 14.18% | $10.64 | $2.32 |
| Sep 2022 | 4.02 | -40.62% | $10.44 | $2.6 |
| Jun 2022 | 6.77 | -45.05% | $12.59 | $1.86 |
| Mar 2022 | 12.32 | -45.7% | $10.84 | $0.88 |
| Dec 2021 | 22.69 | N/A | $14.07 | $0.62 |
| Sep 2021 | N/A | N/A | $19.21 | -$0.33 |
DVAX Price vs fair value
DVAX average PE ratio chart
DVAX PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 11.27 | $194.93B |
| BIIB Biogen Inc | 12.57 | $18.71B |
| PFE Pfizer Inc | 16.81 | $132.87B |
| GILD Gilead Sciences Inc | 22.53 | $133.69B |
| AMGN Amgen Inc | 24.68 | $146.65B |
| AZN Astrazeneca plc | 28.09 | $218.55B |
| AGEN Agenus Inc | N/A | $103.36M |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.2B |
| DVAX Dynavax Technologies Corp | N/A | $1.21B |
Frequently asked questions
What is Dynavax Technologies's PE ratio?
The current price to earnings ratio of DVAX cannot be determined, as its EPS of -$0.49 is negative.
What is the 3-year average PE ratio for Dynavax Technologies (DVAX)?
As an average over the last 3 years, DVAX stock has a PE ratio of 46.5.
What is the 5-year average PE ratio for Dynavax Technologies (DVAX)?
As an average over the last 5 years, DVAX stock has a PE ratio of 41.67.
What is the highest PE ratio for DVAX?
The highest quarterly PE ratio in the last four years has been 177.29 and it was in the Mar 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.